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WIPI3 and WIPI4 b-propellers are scaffolds for
LKB1-AMPK-TSC signalling circuits in the control
of autophagy
Daniela Bakula1,2,*, Amelie J. Mu¨ller1,2,*, Theresia Zuleger1, Zsuzsanna Takacs1,2, Mirita Franz-Wachtel3,
Ann-Katrin Thost1, Daniel Brigger4, Mario P. Tschan4, Tancred Frickey5, Horst Robenek6, Boris Macek2,3
& Tassula Proikas-Cezanne1,2
Autophagy is controlled by AMPK and mTOR, both of which associate with ULK1 and
control the production of phosphatidylinositol 3-phosphate (PtdIns3P), a prerequisite for
autophagosome formation. Here we report that WIPI3 and WIPI4 scaffold the signal control
of autophagy upstream of PtdIns3P production and have a role in the PtdIns3P effector
function of WIPI1-WIPI2 at nascent autophagosomes. In response to LKB1-mediated
AMPK stimulation, WIPI4-ATG2 is released from a WIPI4-ATG2/AMPK-ULK1 complex and
translocates to nascent autophagosomes, controlling their size, to which WIPI3, in complex
with FIP200, also contributes. Upstream, WIPI3 associates with AMPK-activated TSC
complex at lysosomes, regulating mTOR. Our WIPI interactome analysis reveals the scaffold
functions of WIPI proteins interconnecting autophagy signal control and autophagosome
formation. Our functional kinase screen uncovers a novel regulatory link between
LKB1-mediated AMPK stimulation that produces a direct signal via WIPI4, and we show that
the AMPK-related kinases NUAK2 and BRSK2 regulate autophagy through WIPI4.
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A
utophagy1–4 is regulated by AMPK and TORC1, which
activate catabolic and anabolic pathways, respectively, and
interact to control metabolism and maintain energy
homeostasis5,6. In the presence of amino acids and growth
factors, TORC1 becomes activated at the lysosomal surface7.
Activated TORC1 inhibits autophagy through the site-speciﬁc
phosphorylation of the autophagy initiator protein kinase ULK1
(refs 8,9). TORC1-mediated autophagy inhibition is released in
the absence of amino acids and is achieved through the action of
the TORC1 inhibitor complex TSC1–TSC2 (refs 10–12),
which provokes the displacement of TORC1 from
lysosomes13,14. TSC complex activation is regulated through
LKB1-mediated AMPK activation15, which phosphorylates
TSC2 (ref. 16). In addition, AMPK activates ULK1 through
direct phosphorylation9,17, and in turn, ULK1 phosphorylates
components of the phosphoinositide-3 kinase class III (PI3KC3)
complex18,19, allowing phosphatidylinositol 3-phoshpate
(PtdIns3P) production, a prerequisite for autophagosome
formation19–23.
In humans, the PtdIns3P effector function in autophagy is
attributed to the four WIPI proteins, representing the human
group of proteins within the PROPPIN protein family24. WIPI2
functions as a PtdIns3P effector25,26, bridging PtdIns3P
production with the recruitment26 of the ATG16L27,28 complex
for LC3 (refs 29,30) lipidation and subsequent autophagosome
formation25,26,31. WIPI1 (ref. 32) is considered to function
upstream33 and WIPI4 downstream of LC3 (ref. 34); however,
their functions are unknown, and WIPI3 is uncharacterized24.
Despite the notion that glucose starvation induces autophagy
through AMPK-mediated ULK1 phosphorylation9,17, which acts
upstream of WIPI1 and WIPI2 (refs 26,35), neither WIPI1 nor
WIPI2 respond to glucose starvation36,37. Here, we demonstrate
that glucose starvation signals via the LKB1-AMPK network to
WIPI4 in complex with ATG2, which in response contributes to
the regulation of autophagosome formation. WIPI3 is also under
the control of AMPK as it associates with activated TSC complex
in controlling mTOR activity in the lysosomal compartment.
Hence, both WIPI4 and WIPI3 function upstream of PtdIns3P
production but also downstream of WIPI1-WIPI2 in controlling
the size of nascent autophagosomes, with WIPI4 acting in
association with ATG2 and WIPI3 in association with FIP200.
Our study, a combined protein interactome and kinome
screening approach, reveals that the four human WIPI proteins
function as a scaffold circuit, interconnecting autophagy signal
control with autophagosome formation.
Results
WIPI3 and WIPI4 bind PtdIns3P at nascent autophagosomes.
With regard to the reported features of WIPI1 and WIPI2
(refs 25,26,32,38), we assessed WIPI3 and WIPI4 by
comparative39,40 structural modelling (Fig. 1a), phospholipid-
protein overlay assessments38 (Fig. 1b) and subcellular
localization using ﬂuorescence-based confocal laser-scanning
microscopy (LSM) (Fig. 1b–f). Structural homology modelling
using HHpred41 revealed that all WIPI members fold into
seven-bladed b-propellers with an open Velcro topology32
(Fig. 1a). Of note, we used a new WIPI3 sequence in the
current study, as our original WIPI3 cloning isolate32 proved to
represent an N-terminal-truncated version (see Supplementary
Note, Supplementary Fig. 1a–c,h).
As reported42, the binding of WIPI1 and WIPI2 to PtdIns3P at
nascent autophagosomes is demonstrated by the appearance of
subcellular ﬂuorescent puncta (Fig. 1b, right panels,
Supplementary Movies 1 and 2; Supplementary Fig. 1e). The
number of cells displaying GFP-WIPI1 (refs 32,38) and
GFP-WIPI2B31,32 puncta signiﬁcantly increased upon starvation
and decreased upon PI3K inhibition (Fig. 1c), and GFP-WIPI1
and GFP-WIPI2B puncta co-localized with myc-ATG14
(refs 43,44), myc-DFCP1 (refs 31,45), ATG12 (refs 46,47), LC3
(ref. 48) and p62 (ref. 49), as expected (Fig. 1d, Supplementary
Fig. 1f). The numbers of GFP-WIPI1- and GFP-WIPI2B-puncta-
positive cells further increased in the presence of the lysosomal
inhibitor baﬁlomycin A1 (ref. 50) (Fig. 1c), in line with a previous
report on the localization of WIPI1 and WIPI2 at
autophagosomes51.
GFP-WIPI3 and GFP-WIPI4 puncta were smaller in size and
less complex than GFP-WIPI1 and GFP-WIPI2B puncta (Fig. 1b,
right panels, Supplementary Movies 3 and 4; Supplementary
Fig. 1e). The number of GFP-WIPI3-puncta-positive cells
signiﬁcantly increased upon starvation and baﬁlomycin A1
administration and decreased upon PI3K inhibition (Fig. 1c).
The appearance of endogenous WIPI3 puncta upon starvation
was also apparent (Supplementary Fig. 1g). In the following, we
employed GFP-tagged WIPI3, as proper folding was conﬁrmed
through speciﬁc binding to PtdIns3P and PtdIns(3,5)P2 (Fig. 1b,
Supplementary Fig. 1b–d).
The number of GFP-WIPI4-puncta-positive cells increased
upon starvation (Fig. 1c), but this increase was not abolished via
PI3K inhibition (Fig. 1c; Supplementary Fig. 1i). Endogenous
WIPI4 puncta were already prominent in fed conditions, and they
were signiﬁcantly increased upon starvation (Supplementary
Fig. 1j). Both GFP-WIPI3 and GFP-WIPI4 were clearly localized
at nascent autophagosomes, as indicated by their co-localization
with the markers used (myc-ATG14, myc-DFCP1, ATG12, LC3
and p62) (Fig. 1d, Supplementary Fig. 1f). However, the
co-localization of GFP-WIPI4 with myc-ATG14, myc-DFCP1
and endogenous ATG12 was less prominent than that of other
WIPI members (Fig. 1d, Supplementary Fig. 1f). Based on these
ﬁndings, all WIPI proteins appear to co-localize at nascent
autophagosomes. Indeed, the co-localization of endogenous
WIPI2, WIPI4 and GFP-WIPI1 (Fig. 1e) and GFP-WIPI3 with
endogenous WIPI4, myc-WIPI1 and myc-WIPI2B (Fig. 1f) was
apparent.
In summary, all four WIPI members fold into seven-bladed
b-propeller proteins that bind PtdIns3P and localize at nascent
autophagosomes upon starvation.
Autophagosome formation requires WIPI3 and WIPI4.
Using the human melanoma cell line G361, which expresses
detectable levels of all endogenous WIPI members, we generated
stable WIPI knockdown (KD) cell lines (Fig. 2a, Supplementary
Fig. 2a) and scored cells for autophagosomes by electron micro-
scopy (EM) (Fig. 2b, Supplementary Fig. 2b–f, Supplementary
Data 1). Compared with the control cell line (shControl, Fig. 2b,
Supplementary Fig. 2b), WIPI1 KD cells did produce autopha-
gosomes upon starvation (Fig. 2b, panel shWIPI1; Supplementary
Fig. 2c), although we observed a 2.65-fold reduced presence of
autophagosomal structures (Supplementary Data 1). In line with
this ﬁnding, autophagic ﬂux50 assessments by LC3 lipidation
analysis was previously reported to be negatively affected in
WIPI1 KD cells24. Additionally, we here found that starvation-
induced degradation of long-lived proteins52 was signiﬁcantly
reduced in WIPI1 KD cells (Supplementary Fig. 2g). EM of
WIPI2 KD revealed that proper autophagosome formation was
negatively affected as inferred from a 4.93-fold accumulation of
rough endoplasmic reticulum tubular structures (Fig. 2b, panel
shWIPI2; Supplementary Fig. 2d), prominently marking an early
blockade of autophagosome formation26 before phagophore
formation (template membranes from which autophagosomes
emerge23,53) (Supplementary Data 1). In line with this ﬁnding,
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15637
2 NATURE COMMUNICATIONS | 8:15637 | DOI: 10.1038/ncomms15637 | www.nature.com/naturecommunications
the appearance of autophagosomal structures decreased
by 2.94-fold when compared with control cells (Supplementary
Data 1). Moreover, in WIPI2 KD cells, the number of GFP-LC3
puncta was signiﬁcantly reduced (Fig. 2c), corroborating the
previous ﬁnding that WIPI2 is required for LC3 lipidation25,26. The
above results conﬁrm that both WIPI1 and WIPI2 function
upstream of LC3, as previously suggested35. In addition, the results
underline the conception that WIPI2 is required for
autophagosome formation, whereas WIPI1 is dispensable to a
certain degree.
Interestingly, both WIPI3 KD (Fig. 2b, panel shWIPI3;
Supplementary Fig. 2e) and WIPI4 KD (Fig. 2b, panel shWIPI4;
Supplementary Fig. 2f) resulted in the appearance of cup-shaped
double-membrane structures resembling elongated phagophore
formation sites (Fig. 2b, Supplementary Fig. 2e,f; Supplementary
Data 1). In both, WIPI3 KD and WIPI4 KD cells the formation of
autophagosomal structures decreased, respectively, by 6.42- and
3.47-fold when compared with shControl cells (Supplementary
Data 1). In addition, rough endoplasmic reticulum tubular
structures accumulated in the absence of WIPI4, as was observed
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in WIPI2 KD cells (Supplementary Fig. 2f, Supplementary
Data 1). These data suggest that both WIPI3 KD and WIPI4
KD blocked autophagosome formation downstream of WIPI2.
As WIPI2 recruits the ATG16L complex for LC3 lipidation26, we
anticipated that lipidated LC3 would accumulate in the absence of
WIPI3 or WIPI4, which was indeed the case when we looked for
GFP-LC3 puncta using automated high-throughput imaging42
(Fig. 2d). In line with this observation, we also found that
endogenous WIPI2 puncta accumulated in WIPI3 KD and WIPI4
KD cells due to the downstream blockade of LC3 (Fig. 2e).
Moreover, by western blotting we observed a signiﬁcant increase
in basal levels of lipidated (LC3-II) and unlipidated LC3 (LC3-I)
(Fig. 2f, Supplementary Fig. 2h). Upon amino-acid starvation,
however, LC3 levels did not signiﬁcantly change (Supplementary
Fig. 2h), indicating a layer of redundancy between the different
WIPI proteins.
Of additional note, EM observation of WIPI KD in the G361
melanoma cell line showed that WIPI1 and WIPI2 KD cells were
ﬁlled with melanosomes that were not detected in control cells
(Supplementary Fig. 2i). The appearance of melanosomes upon
ULK1 and WIPI1 silencing has been reported54,55. Altogether
with our observation, this suggests that autophagosome and
melanosome formation may be co-regulated56.
WIPI b-propellers are distinct protein interaction platforms.
With regard to the co-localization of all WIPI members at
nascent autophagosomes upon starvation (Fig. 1e,f), we examined
whether WIPI members also associated through protein–protein
interactions. Indeed, using GFP- and myc-tagged WIPI variants31,32,
we found that WIPI1, WIPI2B, WIPI2D and WIPI4 were able to
associate with each other (Supplementary Fig. 3a,b). Next, we
established a WIPI protein interactome using mass spectrometry
(MS)57 upon the immunopuriﬁcation of GFP-tagged WIPI1–4
proteins (Fig. 3). As a control, we employed GFP alone and excluded
the signals from tag-associated proteins from the ﬁnal results, along
with those of proteins giving low peptide counts (see Methods
section, Supplementary Data 2). The WIPI protein interactomes
were generated using GeneMANIA58 (Fig. 3a), and interactions
identiﬁed in this study (red lines) are incorporated with previously
reported59 and predicted interactions (grey lines).
The proteomics analysis demonstrated that all four WIPI
proteins associated in a distinct and non-redundant protein
network. In addition, WIPI1, WIPI2 and WIPI4 share NudC as a
common interaction partner (Fig. 3a,b). We conﬁrmed the
speciﬁc binding of endogenous NudC60–62 with WIPI1, WIPI2B
and WIPI4. Consistent with our MS analysis, NudC did not
co-purify with WIPI3 (Supplementary Fig. 4).
We concentrated our follow-up investigations on ATG proteins
and the known autophagy regulators appearing in our WIPI
interactome network (Fig. 3b). In support of our WIPI interactome
data, we conﬁrmed the reported interaction between WIPI2 and the
ATG16L complex26 (Figs 3a,b and 4a). Moreover, we found that
WIPI2 also interacts with WIPI1 (Fig. 3a,b; Supplementary
Fig. 3a,b), and we provide evidence that WIPI1 likely supports
WIPI2 in ATG16L1 recruitment for LC3 lipidation at nascent
autophagosomes. We show that GFP-WIPI1 associates with
endogenous ATG16L (Figs 3a,b and 4a); however, as we found
only a few peptide counts for ATG16L in our WIPI1 MS analysis
and low amount of ATG16L copurifying with GFP-WIPI1 when
compared with GFP-WIPI2B and GFP-WIPI2D (Fig. 4a), we
suggest that the interaction between WIPI1 and ATG16L occurs
indirectly via WIPI2, in line with previously reported suggestions.
Nevertheless, the functional KD of not only WIPI2 (Fig. 4b) but
also WIPI1 (Fig. 4c) signiﬁcantly reduced the number of
ATG16L-puncta-positive cells. Moreover, WIPI1 depends on
WIPI2 for proper localization to nascent autophagosomes, as
demonstrated by the signiﬁcantly decreased number of GFP-WIPI1
punctate structures in WIPI2 KD cells (Fig. 4d). By contrast, WIPI1
KD had no effect on the number of WIPI2 punctate structures in
fed and starved conditions (Supplementary Fig. 3c), suggesting that
WIPI2 is required for WIPI1 recruitment and that the presence of
the WIPI1-WIPI2 heterodimer may function more efﬁciently in
ATG16L complex recruitment. Moreover, we found that both
WIPI1 KD (Fig. 4e) and WIPI2 KD (Fig. 4f) signiﬁcantly reduced
the number of GFP-WIPI4 punctate structures in fed and starved
conditions, supporting the idea that WIPI1 and WIPI2 function
upstream of WIPI4 during autophagosome formation24.
In support of a role for WIPI3 and WIPI4 downstream of
LC3 (see also Fig. 2d–f), ATG16L puncta accumulated in
WIPI3 KD and WIPI4 KD cells (Fig. 4g). Supporting a role for
WIPI1-WIPI2 upstream of LC3, both GFP-WIPI1- and
GFP-WIPI2B-puncta-positive cells were signiﬁcantly increased
in ATG5 KO conditions due to a blockade of LC3 lipidation
(Fig. 4h,i; Supplementary Movies 5–8). This effect was not
observed when GFP-WIPI3- and GFP-WIPI4-puncta-positive
cells were quantiﬁed in ATG5 KO conditions (Fig. 4i).
WIPI3 associates with the TSC complex and FIP200. Our
WIPI3 protein interactome analysis revealed that WIPI3 likely
connects to the autophagic machinery through associations
Figure 1 | All WIPI members fold into seven-bladed b-propeller proteins that bind PtdIns3P and co-localize at nascent autophagosomes. (a) Structural
homology modelling using HHpred. Propeller blades are indicated (1 to 7), and unstructured sequences are omitted. (b) Protein-phospholipid binding
overlay assays using G361 cell extracts followed by the detection of endogenous WIPI1, WIPI2 or WIPI4 or using a monoclonal U2OS cell line stably
expressing GFP-WIPI3 followed by anti-GFP enhanced chemiluminescence (ECL) detection (left panels). Monoclonal U2OS cell lines stably expressing
GFP-WIPI1, GFP-WIPI2B or GFP-WIPI3 or transiently expressing GFP-WIPI4 were starved for 3 h with nutrient-free medium. Images were acquired by
confocal LSM and processed using Volocity to generate 3D-reconstruction ﬂy-through movies (Supplementary Movies 1–4). Representative still images are
presented (right panels). Scale bars: 3 mm. (c) U2OS cells stably expressing GFP-WIPI1, GFP-WIPI2B or GFP-WIPI3 or transiently expressing GFP-WIPI4
were fed (F) or starved (S) for 3 h with or without baﬁlomycin A1 (BafA1) or LY294002 (LY). The percentage GFP-WIPI puncta cells were calculated (up to
429 cells per condition, n¼ 3). (d) U2OS cells stably expressing GFP-WIPI1, GFP-WIPI2B or GFP-WIPI3 or transiently expressing GFP-WIPI4 were starved
(3 h), and endogenous ATG12, LC3, p62 (anti-ATG12, anti-LC3, anti-p62 and IgG-Alexa Fluor 546 antibodies) or transiently expressed myc-tagged ATG14
or DFCP1 detected (anti-myc/IgG-Alexa Fluor 546 antibodies). Merged confocal LSM images are presented (left panels, dashed lines: cell boundaries; right
panels: magniﬁed subsections). Scale bars: 20mm. (e) Confocal LSM examinations of starved (3 h) U2OS cells stably expressing GFP-WIPI1 and
immunostained with anti-WIPI2/IgG-Alexa Fluor 546 and anti-WIPI4/IgG-Alexa Fluor 633 antibodies. Intensity proﬁles of co-localizations (peaks 1 and 2,
upper panel) are displayed, along with the corresponding magniﬁed image sections. Scale bar: 2.5 mm. (f) U2OS cells stably expressing GFP-WIPI3 and
transiently expressing myc-tagged WIPI1 or WIPI2B were starved (3 h) and immunostained using anti-myc or anti-WIPI4 and IgG-Alexa Fluor 546
antibodies. Scale bar: 2.5mm. Arrows in magniﬁed image sections indicate co-localization events (d–f). Supplementary Material is available: Supplementary
Fig. 1, Supplementary Note. Statistics and source data can be found in Supplementary Data 1. Mean±s.d.; heteroscedastic t-testing; P values: *Po0.05,
**Po0.01, ***Po0.001, ns: not signiﬁcant.
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Figure 2 | Differential contributions of WIPI members to the formation of functional autophagosomes. G361 cell lines stably expressing shRNAs
targeting WIPI1 (shWIPI1), WIPI2 (shWIPI2), WIPI3 (shWIPI3), WIPI4 (shWIPI4) or non-targeting shRNA (shControl) were assessed by quantitative
RT–PCR (a) or electron microscopy analysis upon starvation (3 h), scale bars: 500nm (b). (c) Monoclonal U2OS cell lines stably expressing GFP-LC3 and
shWIPI2 or shControl were assessed by quantitative RT–PCR (left panel). Automated high-throughput image acquisition (middle panel, upper row: dashed
lines indicate cell boundaries; lower row: magniﬁed sections) and analysis (right panel). The numbers of GFP-LC3 puncta in control (shRNA) or WIPI2-KD
(shWIPI2) cells were calculated under fed (F) or starved (S) conditions with or without wortmannin (WM) or baﬁlomycin A1 (BafA1). The mean number of
GFP-LC3 puncta per cell was calculated (up to 15,401 cells per condition, n¼ 3). Scale bars: 20mm. (d) U2OS cells stably expressing GFP-LC3 were
transiently transfected (48 h) with control siRNA (siControl) or siRNAs targeting WIPI3 (siWIPI3) or WIPI4 (siWIPI4). Total RNA was extracted for
quantitative RT–PCR (left panel: WIPI3, middle panel: WIPI4). In addition, fed cells (F) cells were treated with or without of BafA1 for automated
high-throughput image analysis (right panel). Mean numbers of GFP-LC3 puncta per cell are presented (up to 2,680 cells per condition, n¼ 3).
(e) Endogenous WIPI2 puncta formation was examined (anti-WIPI2/IgG-Alexa Fluor 488 antibodies) by confocal LSM and ImageJ (least 15 cells, n¼ 3)
using stable G361 WIPI3-KD (shWIPI3), WIPI4-KD (shWIPI4) and control cells (shControl). (f) G361 cells were transiently transfected with control siRNA
(siControl), siWIPI3, siWIPI4 or a siWIPI3/siWIPI4 combination and fed (F) or starved (S) for 3 h with or without BafA1. Cell lysates were analysed by
anti-LC3 and anti-tubulin western blotting. The migrations of LC3-I and LC3-II are indicated (left panel). LC3-I (middle panel) and LC3-II (right panel)
abundances were quantiﬁed and results achieved in fed conditions (F) are presented (n¼ 3). Supplementary Material is available: Supplementary Fig. 2.
Statistics and source data can be found in Supplementary Data 1. Mean±s.d.; heteroscedastic t-testing; P values: *Po0.05, **Po0.01, ***Po0.001, ns: not
signiﬁcant.
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with the obligatory hetero-dimer TSC1-TSC2 (refs 10,12) and
with FIP200 (refs 63–65) (Fig. 3). The speciﬁc interaction
between WIPI3 and the TSC complex was demonstrated by
immunopuriﬁcation of both endogenous TSC1 and TSC2 with
GFP-WIPI3 (Fig. 5a). The ﬁndings of this analysis further
revealed that GFP-WIPI3 interacts with TSC2 phosphorylated
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at serine 1,387 (Fig. 5a), an AMPK-speciﬁc phosphorylation
site required for TSC-mediated TORC1 inhibition16. The
interaction between the TSC complex and endogenous
WIPI3, but not WIPI1, WIPI2 or WIPI4 has also been
conﬁrmed (Fig. 5b) and, as anticipated, is independent of
ATG5 as shown by using GFP-WIPI3 in mouse embryonic
ﬁbroblasts (MEFs) depleted from ATG5 (Fig. 5c). Moreover, we
observed that the association of GFP-WIPI3 with the
endogenous TSC complex appeared to be more abundant in
starved (S) cells (Fig. 5c,d). Furthermore, the association
between GFP-WIPI3 and the TSC complex was not
dependent on PtdIns3P production because the complex
formed despite the addition of the PI3K inhibitor LY294002
to the starved cells (Fig. 5d). Of note, a greater degree
of complex formation was again apparent in starved cells
(S, 150–3 h) than in fed cells (Fig. 5d). Furthermore,
we overexpressed full-length TSC1 (TSC-FL), a TSC1
fragment corresponding to the middle part of the protein
(TSC1-M), which has previously been shown to interact with
FIP200 (ref. 66), or a C-terminal fragment of TSC1 (TSC1-C),
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and found that GFP-WIPI3 clearly co-immunoprecipitated
with TSC1-M (Fig. 5e).
Because the active TSC complex localizes to lysosomes
for TORC1 inhibition, we enriched lysosomes and found that
GFP-WIPI3 co-fractionated with endogenous TSC2 and LAMP2
(ref. 67), marking lysosomes/late endosomes (Fig. 5f). This result
was conﬁrmed by confocal LSM, which showed that GFP-WIPI3
co-localized with endogenous TSC2 and LAMP2 in starved cells
(Fig. 5g; Supplementary Fig. 5a). In addition, WIPI3 also localized
at nascent autophagosomes upon starvation (see also Fig. 1d–f),
and co-localizing GFP-WIPI3 and endogenous WIPI2 puncta
were negative for LAMP2 (Fig. 5h; Supplementary Fig. 5b). In fed
cells GFP-WIPI3 also co-localized with LAMP2, however, this
co-localization was more apparent upon lysosomal inhibition by
baﬁlomycin A1 (Supplementary Fig. 5c, upper panel) and
was sensitive to PI3K inhibition (Supplementary Fig. 5c, lower
panel). TSC2 KD signiﬁcantly reduced the number of
GFP-WIPI3- (Fig. 5i), GFP-WIPI1- and GFP-LC3-puncta-
positive cells (Supplementary Fig. 5d). As the TSC complex
displaces mTOR from the lysosomal surface for TORC1
inhibition, we anticipated that WIPI3 would not localize to
LAMP2-positive lysosomes/late endosomes upon TORC1 stimu-
lation, as indicated by site-speciﬁc ULK phosphorylation (S757 in
mice and S758 in humans), mTOR autophosphorylation (Fig. 5j)
and lysosomal positioning (Fig. 5k; Supplementary Fig. 5e).
Indeed, upon TORC1 stimulation, GFP-WIPI3 was not detected
at lysosomes (LAMP2-positive lysosomes/late endosomes) posi-
tive for endogenous mTOR (Fig. 5k; Supplementary Fig. 5e).
These data suggest that WIPI3 functions in association with the
TSC complex to regulate mTOR activity in the lysosomal
compartment.
To further examine the possibility of an additional function of
WIPI3 at nascent autophagosomes, we also assessed the
WIPI3-FIP200 interaction identiﬁed in the MS analysis (Fig. 3).
GFP-WIPI3 clearly associated with endogenous FIP200 in MEFs
(Fig. 6a). Upon starvation, GFP-WIPI3 strongly co-localized with
endogenous FIP200, myc-tagged WIPI2B (Fig. 6b; Supplementary
Fig. 6a) and endogenous p62 (Fig. 6c; Supplementary Fig. 6b).
FIP200 KD (Fig. 6d) signiﬁcantly reduced the number of
GFP-WIPI3-puncta-positive cells present upon starvation
(Fig. 6e) and reduced the number of GFP-WIPI1 (Fig. 6f) and
GFP-LC3 (Fig. 6g) puncta.
Moreover, as FIP200 has also been reported to have additional
functions and to interact with TSC1, we examined whether
WIPI3 was found together with FIP200 in the lysosomal
compartment. Indeed, GFP-WIPI3 co-localized with endogenous
FIP200 and LAMP2-positive lysosomes/late endosomes upon
starvation (Fig. 6h, upper panel; Supplementary Fig. 6c), which
was abolished upon amino acid-induced TORC1 stimulation
(Fig. 6h, lower panel; Supplementary Fig. 6c). These data argue
that WIPI3 interacts with FIP200 at nascent autophagosomes and
at LAMP2-positive lysosomes/late endosomes.
The WIPI4 complex contains ATG2, AMPK and ULK1. WIPI4
is considered to function, together with ATG2, downstream of
LC3 at nascent autophagosomes24. Our MS analysis of WIPI4
protein interaction partners highlighted an association between
WIPI4 and ATG2 (ATG2A, ATG2B) (Fig. 3), which we
conﬁrmed by co-immunoprecipitation (Fig. 7a). By mutating
individual amino acids in WIPI4 that are conserved in human
WIPI proteins32 (Supplementary Fig. 1a) we identiﬁed two
critical residues in WIPI4, N15 and D17, that confer ATG2A
binding (Fig. 7b, Supplementary Fig. 7a). A phospholipid-binding
mutant of WIPI4 (WIPI4-R232A/R233A, Supplementary Fig. 7a)
was able to bind to ATG2A, in line with the previous suggestion
that the phospholipid-binding site in all WIPI proteins is
positioned on one side of the b-propeller, whereas the capacity
for speciﬁc protein–protein interactions is conferred by
homologous residues on the opposite site32.
Next, we silenced WIPI4 and ATG2 and found that their
combined KD (Fig. 7c) and the KD of ATG2 alone (Fig. 7d)
provoked massive accumulations of WIPI1-positive membranes
(Fig. 7c,d). Using automated high-throughput image analysis, we
veriﬁed this result, as the size and number of both GFP-WIPI1
and GFP-LC3 (Fig. 7e) punctate structures signiﬁcantly increased
upon ATG2 KD. This observation suggests that the WIPI4-ATG2
complex at nascent autophagosomes is required for controlling
their size downstream of the effects of LC3, which is in line
with the appearance of cup-shaped double-membrane structures
resembling elongated phagophore formation sites upon
WIPI4 KD (Fig. 2b) and the reduced number of GFP-WIPI4-
puncta-positive cells upon WIPI1 KD (Fig. 4e) and WIPI2 KD
(Fig. 4f).
Our MS analysis of WIPI4-interacting proteins further revealed
that AMPK likely interacts with WIPI4 (Fig. 3, Supplementary
Data 2), which we assessed using GFP-WIPI4, and GFP-WIPI2B
as well as GFP alone as negative controls (Fig. 7f). In
fed conditions, we detected endogenous AMPK in the
WIPI4-ATG2A immunoprecipitate, but we found less in starved
conditions (Fig. 7f). Moreover, the WIPI4-ATG2A complex
also contained endogenous ULK1 (Fig. 7g), which we did not
identify in the MS analysis but which is known to interact
with AMPK and to be used as an AMPK substrate upon
Figure 4 | WIPI1 assists WIPI2 in recruiting ATG16L for LC3 lipidation. (a) U2OS cells transiently expressing GFP-WIPI1, GFP-WIPI2B, GFP-WIPI2D,
GFP-WIPI3, GFP-WIPI4 or GFP alone were starved for 3 h and analysed by anti-GFP immunoprecipitation followed by anti-GFP or anti-ATG16L
immunoblotting. The asterisk in the right panel (GFP-IP) represents a nonspeciﬁc band. Endogenous ATG16L isoforms co-precipitated with GFP-WIPI1,
GFP-WIPI2B and GFP-WIPI2D as indicated in the right panel. (b,c) G361 cells stably expressing shRNA targeting WIPI2 (b, shWIPI2), WIPI1 (c, shWIPI1) or
the non-targeting control (shControl) were fed (F) or starved (S) for 3 h, and endogenous ATG16L was detected using anti-ATG16L/IgG-Alexa Fluor 488
antibodies and ﬂuorescence microscopy. Mean percentages of ATG16L-puncta-positive cells (up to 369 individual cells per condition, n¼ 3) are presented.
(d) Monoclonal U2OS cells stably expressing GFP-WIPI1 and shWIPI2 or shControl were starved (S) for 3 h, and the percentage of cells displaying an
accumulation of perinuclear GFP-WIPI1 was calculated using ﬂuorescence microscopy. Mean values (400 cells per condition, n¼4) are presented.
(e,f) G361 cells stably expressing shRNAs targeting WIPI1 (e, shWIPI1) or WIPI2 (f, shWIPI2) were fed (F) or starved (S) for 3 h and immunostained using
anti-WIPI4/IgG-Alexa Fluor 488 antibodies. Mean percentages of WIPI4-puncta-positive cells (up to 340 cells per condition, n¼ 3) are presented.
(g) G361 cells stably expressing shRNAs targeting WIPI3 (shWIPI3), WIPI4 (shWIPI4) or the non-targeting shRNA control (shControl) were fed (F) or
starved (S) for 3 h and immunostained using anti-ATG16L/IgG-Alexa Fluor 488 antibodies for analysis by ﬂuorescence microscopy (left panel). Mean
percentages of ATG16L-puncta-positive cells (up to 387 cells per condition, n¼ 3) are presented (right panel). (h,i) ATG5 wild-type (WT) or knockout (KO)
mouse embryonic ﬁbroblasts (MEFs) transiently expressing GFP-WIPI1, GFP-WIPI2B, GFP-WIPI3 or GFP-WIPI4 were analysed by confocal LSM, and
images from ATG5 WT MEFs (h, upper panel) were processed using Volocity to generate 3D-reconstruction ﬂy-through movies (Supplementary Movies
5–8), from which still images are presented (h, lower panel). Mean percentages of GFP-WIPI puncta-positive cells (300 cells, n¼ 3). Mean±s.d.;
heteroscedastic t-testing; P values: *Po0.05, ns: not signiﬁcant. Scale bars: 20mm. Statistics and source data can be found in Supplementary Data 1.
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starvation68. By overexpressing HA-tagged ULK1, we conﬁrmed
the association between GFP-WIPI4 and HA-ULK1 in fed
conditions (Supplementary Fig. 7b). These results demonstrate
that WIPI4-ATG2A interacts with AMPK-ULK1 in fed
conditions but less upon AMPK activation. Using the
pharmacological compound AICAR (5-aminoimidazole-4-
carboxamide ribonucleotide), which speciﬁcally activates
AMPK, the interaction of WIPI4-ATG2A and AMPK-ULK1
was further reduced (Fig. 7h, Supplementary Fig. 7c), which
is underlined by quantifying the abundance of
co-immunoprecipitated AMPK with GFP-WIPI4 (Fig. 7i).
As AMPK is activated upon glucose starvation, we deprived
cells of glucose, either alone or in combination with glutamine
(Fig. 7j). In line with the results presented above, we detected
AMPK in complex with WIPI4-ATG2A in fed conditions but
reduced upon glucose starvation (Fig. 7j). Using overexpressed
AMPK subunits a1-g1, the association between WIPI4 and
AMPK was further conﬁrmed in fed conditions (Fig. 7k,
Supplementary Fig. 7d).
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WIPI4 is stimulated by AMPK, NUAK2 and BRSK2. To
address the functional relevance of AMPK in the control of WIPI
proteins, we screened a lentiviral short hairpin RNA (shRNA)
library, individually targeting all human protein kinases, and
identiﬁed the regulatory AMPKg subunit and two AMPK-related
protein kinases, NUAK2 and BRSK2, that together with AMPK,
are functionally and physically regulated as a network through
LKB1 (ref. 69) (Fig. 8a; Supplementary Fig. 8a,b; see Methods
section for details). Based on this result, we knocked down
AMPKa1/2, AMPKg1, NUAK2 and BRSK2 or their upstream
kinase, LKB1, using transient short interfering RNA (siRNA)
transfections (Fig. 8b) in the following experiments. Strikingly,
we found a signiﬁcantly reduced number of GFP-WIPI4-puncta-
positive cells upon amino-acid starvation (Fig. 8c). This result
suggests that LKB1/AMPK signalling upon amino-acid starvation
is, in addition to its reported effects leading to TORC1 inhibition
and ULK1 stimulation, also directed towards WIPI4-ATG2,
which we identiﬁed to be associated with AMPK-ULK1 in fed but
less in starved conditions (Fig. 7). In line with this observation, we
found that glucose and glucose plus glutamine starvation, which
activated AMPK as expected (Fig. 8d), provoked a signiﬁcant
increase in GFP-WIPI4 punctate structures (Fig. 8e), which
was not the case when GFP-WIPI1 (Fig. 8f) punctate structures
were assessed by automated imaging, supporting the ﬁndings of
previous reports35,36. Further, using our panel of WIPI4 mutants
(Supplementary Fig. 7a) we found that WIPI4 D113A was
impaired in binding to AMPK (Supplementary Fig. 8c).
Employing the GFP-WIPI4 D113A mutant (Fig. 8g,h), we
found that this mutant did not respond to glucose starvation
with an increase in the formation of punctate structures when
compared with wild-type GFP-WIPI4 (Fig. 8g). Moreover,
whereas GFP-WIPI4-puncta-positive structures signiﬁcantly
decreased in AMPK KD conditions (Fig. 8c,h), GFP-WIPI4
D113A punctate structures did not (Fig. 8h).
Discussion
The human WIPI2 b-propeller protein (WIPI2B and WIPI2D)
functions as an essential PtdIns3P effector at nascent
autophagosomes26; however, the contributions of the other WIPI
proteins, WIPI1 and WIPI4, in autophagy remained obscure, and
WIPI3 was entirely uncharacterized24. Here we provide evidence
that all human WIPI proteins function as scaffold building units
that interlink the control of autophagy with the formation of
functional autophagosomes. We used a combined proteomics and
kinome screening approach and identiﬁed the WIPI interactome
and the associated regulatory protein kinases. Our study shows that
WIPI proteins function as scaffolds with distinct associations to
both critical regulators of autophagy and each other.
We show that WIPI1 (refs 32,70) interacts with WIPI2 (WIPI2B
and WIPI2D31) and that it supports the PtdIns3P-effector function
of WIPI2 (refs 25,26) in autophagy, which is the recruitment of the
ATG16L complex for LC3 lipidation26. Although WIPI2 silencing
more prominently interferes with autophagosome formation, fewer
autophagosomes form and less proteolysis occurs in the absence of
WIPI1, which is consistent with a supporting role of WIPI1 for
WIPI2.
At nascent autophagosomes, WIPI1-WIPI2 co-localizes with
WIPI4 (refs 32,34), and in co-immunoprecipitation and
proteomics analyses, we also found that WIPI1, WIPI2 and
WIPI4 co-associate. In addition, WIPI1, WIPI2 and WIPI4 share
NudC60–62 as a novel partner protein. Moreover, we found
that WIPI4 directly associates with ATG2 (refs 40,43,71–73)
(via N15/D17) and that this complex also contains AMPK and
ULK1 in fed conditions. Upon starvation and AMPK activation,
WIPI4-ATG2 dissociates from AMPK and ULK1 and localizes at
nascent autophagosomes, potentially supporting further
autophagosome maturation. WIPI4, ATG2 or combined
WIPI4/ATG2 silencing arrests autophagosome formation and
increases the accumulation of early and intermediate structures,
arguing for a role of WIPI4-ATG2 in controlling the extent of
autophagosomal membrane formation. This function is initiated
by LKB1-mediated AMPK activation15,69, demonstrating that
AMPK controls not only PtdIns3P production via ULK1
activation68 but also appropriate autophagosome formation via
WIPI4-ATG2. The AMPK link with WIPI4-ATG2 is further
supported by our ﬁnding that glucose starvation triggers an
increase in WIPI4 localization at nascent autophagosomes, which
others and we did not observe when analysing WIPI1 and WIPI2
(refs 36,37). This ﬁnding is supported by the results of
our kinome screening, which identiﬁed AMPK and the
AMKP-related kinases NUAK2 and BRSK2, all of which
function downstream of LKB1 (ref. 69) and stimulate the
localization of WIPI4 to nascent autophagosomes.
LKB1-AMPK signalling further triggers the activation of
TSC1-TSC2 (refs 10–12), which inhibits mTOR activity at
lysosomes13,14. Interestingly, analysis of the WIPI3 interactome
revealed a speciﬁc interaction of WIPI3 with the TSC complex,
and we demonstrated that WIPI3 binds to the TSC complex
when TSC2 is phosphorylated at serine 1,387 (S1387), an
AMPK target site16. Moreover, we detected both WIPI3 and the
TSC complex in the lysosomal compartment upon starvation
but not when mTOR was activated. The region in TSC1 to
Figure 5 | WIPI3 interacts with the TSC complex. (a) Stable GFP-WIPI1, GFP-WIPI2B, GFP-WIPI3 or GFP-WIPI4 U2OS cells were starved (3 h), and
subjected to anti-GFP immunoprecipitation and anti-TSC2, anti-phospho-TSC2 (S1387), anti-TSC1 or anti-GFP immunoblotting. (b) U2OS cells were
analysed by anti-TSC1 immunoprecipitation (TSC1-IP), anti-TSC1, anti-TSC2 and anti-WIPI1 (right panel), anti-WIPI2 (right panel), anti-WIPI3 (left panel)
or anti-WIPI4 (right panel) immunoblotting. (c) ATG5 WT or KO MEFs expressing GFP-WIPI3 (W3) or GFP were subjected to anti-GFP
immunoprecipitation and anti-TSC1, anti-TSC2 and anti-GFP immunoblotting. Conditions (3 h): fed (F) or starved (S). (d) Stable GFP-WIPI3 or GFP U2OS
cells were analysed by anti-GFP immunoprecipitation and anti-TSC2 and anti-GFP immunoblotting. Conditions (15min. to 3 h): fed (F), starved (S), starved
with LY294002 (Sþ LY). (e) Myc-tagged TSC1 fragments (TSC1-M, TSC1-C; full length: TSC-FL) were expressed in stable GFP-WIPI3 U2OS cells and
subjected to anti-GFP immunoprecipitation and anti-GFP or anti-myc immunoblotting. (f) Lysosomal fractions (no. 1–7; total protein control: TP) from
stable GFP-WIPI3 U2OS cells (BafA1, 3 h) were immunoblotted using anti-GFP, anti-LAMP2, anti-TSC2, anti-WIPI2 or anti-Rab4 antibodies. (g) Stable
GFP-WIPI3 U2OS cells were starved (3 h) and immunostained with anti-TSC2/IgG-Alexa Fluor 546 and anti-LAMP2/IgG-Alexa Fluor 633 antibodies for
confocal LSM. (h) Stable GFP-WIPI3 U2OS cells were immunostained with anti-Lamp2/IgG-Alexa Fluor 633 and anti-WIPI2/IgG-Alexa Fluor 546 for
confocal LSM. Conditions (3 h): fed (F), starved (S). (i) Stable GFP-WIPI3 U2OS cells with siControl or siTSC2 were fed (F) or starved (S) with or without
BafA1 (3 h). Upper panel: anti-TSC2 immunoblotting, lower panel: GFP-WIPI3 puncta assessment (up to 493 cells per condition, n¼4). (j) U2OS cells were
subjected to immunoblotting using anti-phospho-mTOR (S2481), anti-mTOR, anti-phospho-ULK1 (S757), anti-ULK1 and anti-tubulin antibodies.
Treatments: fed (F, 4 h), starved (S, 4 h), starved (3 h) and fed (1 h) (S-F). (k) Stable GFP-WIPI3 U2OS cells were immunostained with
anti-mTOR/IgG-Alexa Fluor 546 and anti-LAMP2/IgG-Alexa Fluor 633 antibodies. Treatments: starved (S, 2 h), starved (2 h) and fed (1 h) (S-F).
Co-localizations are indicated with arrows (g,h,k). Supplementary Material is available: Supplementary Fig. 5. Statistics and source data: Supplementary
Data 1. Mean±s.d.; heteroscedastic t-testing; P values: *Po0.05, **Po0.01, ***Po0.001. Scale bars: 3 mm.
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which WIPI3 binds overlaps with the reported binding site for
FIP200 (ref. 66). In line with this ﬁnding, we also identiﬁed and
veriﬁed a speciﬁc interaction between WIPI3 and FIP200, from
which we suggest that WIPI3 functions as a scaffold between
the TSC complex and FIP200. In support of this idea, we found
that WIPI3 co-localizes with FIP200 in the lysosomal
compartment, a reported localization of FIP200 with
unknown consequences74. The data presented here suggest
that WIPI3 in complex with TSC1-TSC2 and FIP200
co-regulates mTOR activity; in line with this hypothesis,
WIPI3 was found to be absent from lysosomes when mTOR
was present. Our results further emphasize that FIP200
performs numerous roles in autophagy, acting as part of the
ULK1 complex63, together with WIPI3 and the TSC complex at
lysosomes, and at nascent autophagosomes, where direct
binding between FIP200 and ATG16L has been reported75,76.
Upon starvation, WIPI3 also translocates to the nascent
autophagosome, where it co-localizes with FIP200 and all
other WIPI proteins and ATG members examined. WIPI3
deﬁciency arrests autophagosome formation, indicating that
WIPI3 also has a role in the formation of functional
autophagosomes.
Taken together, our data reveal the WIPI interactome and
suggest that the LKB1-AMPK regulatory network directly or
indirectly regulates the scaffold functions of the four human
WIPI proteins. Our work provides a framework for further
studies concentrating in more detail on the various new aspects
presented here.
Methods
Antibodies. The following primary antibodies were used in this study: AMPKa
(Cell Signaling; #2,532; WB 1:1,000), AMPKg1 (Cell Signaling; #4,187; WB
1:1,000), Phospho-AMPKa (Thr172) (Cell Signaling; #2,531; WB 1:1,000), ATG12
(Abgent; AP1816a; IF 1:25), ATG16L (CosmoBio; CAC-TMD-PH-ATG16L; WB
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Figure 6 | WIPI3 interacts with FIP200 at nascent autophagosomes and at LAMP2-positive lysosomes/late endosomes. (a) Mouse embryonic
ﬁbroblasts transiently expressing GFP-WIPI3 or GFP alone were fed (F) or starved (S) for 3 h and analysed by immunoprecipitation using anti-GFP
antibodies and anti-FIP200 or anti-GFP immunoblotting. (b) U2OS cells stably expressing GFP-WIPI3 were transfected with myc-WIPI2B and starved (S) in
the absence or presence of BafA1 for 3 h. Cells were immunostained with anti-myc/IgG-Alexa Fluor 546 or anti-FIP200/IgG-Alexa Fluor 633 antibodies
and visualized by confocal LSM. (c) U2OS cells stably expressing GFP-WIPI3 were starved (S) in the absence or presence of BafA1 for 3 h, immunostained
with anti-FIP200/IgG-Alexa Fluor 546 and anti-p62/IgG-Alexa Fluor 633 antibodies and visualized by confocal LSM. (d,e) U2OS cells stably
overexpressing GFP-WIPI3 were transfected with control siRNA or FIP200 siRNA. Subsequently, the cells were starved for 3 h in the absence or presence
BafA1. FIP200 downregulation was conﬁrmed by immunoblotting using anti-FIP200 and anti-tubulin antibodies (d). Mean percentages of GFP-WIPI3-
puncta-positive cells (up to 481 cells per condition, n¼4) are presented (e). (f) U2OS cells stably overexpressing GFP-WIPI1 were transfected with control
siRNA or FIP200 siRNA. Subsequently, the cells were starved for 3 h with nutrient-free medium in the absence or presence BafA1. Using automated image
acquisition and analysis, the mean percentages of GFP-WIPI1-puncta-positive cells (up to 5,856 cells per condition, n¼4) were calculated. (g) In parallel,
this experiment was conducted using GFP-LC3-expressing U2OS cells and mean numbers of GFP-LC3 puncta per cell (up to 4,798 cells per condition,
n¼4) calculated. (h) U2OS cells stably expressing GFP-WIPI3 were starved (S) for 2 h or starved and replenished with amino acids for 1 h (S-AAs).
Subsequently, cells were immunostained with anti-FIP200/IgG-Alexa Fluor 546 and anti-LAMP2/IgG-Alexa Fluor 633 antibodies and visualized by
confocal LSM. Image magniﬁcations are presented (b,c,h) and co-localizations indicated with white arrows. Supplementary Material is available:
Supplementary Fig. 6. Statistics and source data can be found in Supplementary Data 1. Mean±s.d.; heteroscedastic t-testing; P values: *Po0.05,
**Po0.01, ***Po0.001, ns: not signiﬁcant. Scale bars: 3mm.
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1:1,000; IF 1:25), CaMKKa (Santa Cruz; sc-136280; WB 1:1,000), FIP200 (Cell
Signaling; #12,436; WB 1:1,000; IF 1:100), GAPDH (Acris; ACR001P; WB
1:50,000), GFP (Roche; #11814460001; WB 1:1,000), HA.11 (Biolegend;
MMS-101R; WB 1:1,000), LAMP2 (Santa Cruz; sc-18,822; WB 1:1,000; IF 1:50),
LC3 (Nanotools; 0231-100/LC3-5F10; WB 1:1,000, IF 1:5), LKB1 (Cell Signaling;
#3,047; WB 1:1,000), c-myc (SantaCruz; sc-40, sc-789; WB 1:1,000; IF 1:200),
NudC (Abgent; AT3125a; WB 1:1,000), p62 (Santa Cruz; sc-28,359; WB 1:1,000; IF
1:50), Rab4 (BD Transduction Laboratories; 610,888; WB 1:1,000), mTOR (Cell
Signaling; #2,983; WB 1:1,000; IF 1:400), Phospho-mTOR (Ser2481) (Cell
Signaling; #2,974; WB 1:1,000), Hamartin/TSC1 (Cell Signaling; #6,935, #4,906;
WB 1:1,000), Tuberin/TSC2 (Cell Signaling; #4,308; WB 1:1,000; IF 1:800),
Phospho-Tuberin/TSC2 (Ser1387) (Cell Signaling; #5,584; WB 1:1,000), aTubulin
(Sigma-Aldrich; T5168; WB 1:50,000), gTubulin (Sigma-Aldrich; T3559; WB
1:50,000), ULK1 (Cell Signaling; #8,054; WB 1:1,000), Phospho-ULK1 (Ser757)
(Cell Signaling; #6,888; WB 1:1,000), WIPI1 (Abnova; H00055062-M02; WB
1:1,000; IF 1:25), WIPI2 (Abgent; AP9559b; WB 1:250; IF 1:25), WIPI3/WDR45L
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(Sigma-Aldrich; HPA017886; IF 1:25), WIPI3 (Santa Cruz; sc-514194; WM 1:500),
WIPI4/WDR45 (Abnova; H00011152-B01P; WB 1:200; IF 1:25).
For immunoﬂuoresence the following secondary antibodies were purchased
from Molecular Probes/Life Technologies: Alexa Fluor 488 goat anti-rabbit IgG
(A-11008; IF 1:200), Alexa Fluor 488 goat anti-mouse IgG (A-11001; IF 1: 200),
Alexa Fluor 546 goat anti-rabbit IgG (A-11010; IF 1:200), Alexa Fluor 546 goat
anti-mouse IgG (A-11003; IF 1:200), Alexa Fluor 633 goat anti-rabbit IgG
(A-21070; IF 1:200), Alexa Fluor 633 goat anti-mouse IgG (A-21050; IF 1:200).
For immunoblotting the following secondary antibodies were used in this study:
anti-rabbit IgG, horseradish peroxidase (HRP)-linked (GE Healthcare; NA934V;
WB 1:10,000), anti-mouse IgG, HRP-linked (GE Healthcare; NA931V; WB
1:10,000), anti-rabbit IgG, HRP-linked (Cell Signaling; #7,074; WB 1:10,000),
anti-mouse IgG, HRP-linked (Cell Signaling; #7,076; WB 1:10,000).
Short interfering RNAs. The following siRNAs were used in this study: WIPI2
(EHU095551), WIPI3/WDR45L (EHU109971), WIPI4/WDR45 (EHU023161)
and the control esiRNA targeting FLUC (EHUFLUC) were purchased from
Sigma-Aldrich. TSC2/Tuberin (#6,476) and control siRNA (#6,568) were
purchased from Cell Signaling. ATG2A (sc-96,345), AMPKa1/2 (sc-45,312),
AMPKg1 (sc-38,929), BRSK2 (sc-96,315), CaMKKa (sc-29,904), LKB1 (sc-35,816),
NUAK2/SNARK (sc-88,608), NudC (sc-88,034), TSC1/hamartin (sc-37,437),
FIP200/RB1CC1 (sc-38,211), and control siRNA-A (sc-37,007) were purchased
from Santa Cruz.
Complementary DNA (cDNA) constructs. GFP-WIPI1, GFP-WIPI2B,
GFP-WIPI2D, GFP-WIPI3S, GFP-WIPI4, myc-WIPI1, myc-WIPI2B, as well as
myc-WIPI2D were previously reported31,32. Myc-ATG2A, myc-ATG14 and
myc-DFCP1 were also previously reported31,43. Cloning of GFP-WIPI3 was
conducted by using the following oligonucleotides: forward primer: 50-agagagctc
gagctatggattccggcgccatgaac-30 , reverse primer: : 50-agagagggatcctcacagcttgtcatcggt
cag-30 . This WIPI3 cDNA sequence encoded an N-terminal extension
(Supplementary Fig. 1a, Supplementary Note, GeneBank accession number
KX434429) when compared with the original sequence (AY691427.1) (ref. 32).
The GFP-LC3 (refs 29,48) plasmid was kindly provided by Tamotso Yoshimori,
Osaka University, Japan. Myc-AMPKa1 was generated by subcloning the human
AMPKa1 cDNA (Addgene plasmid #20,595: pWZL Neo Myr Flag PRKAA1 was a
gift from William Hahn and Jean Zhao77) into pCMV-Tag3b (XhoI/ApaI) using
the following oligonucleotides: forward primer: 50-agagagctcgagatggcgacagccgagaag
cag-30 , reverse primer: 50-agagaggggccccaattgtgcaagaattttaattag-30 . Myc-AMPKa2
was generated by subcloning human AMPKa2 cDNA (Addgene plasmid #31,654:
pECE-HA-AMPKalpha2 wt was a gift from Anne Brunet78) into pCMV-Tag3b
(BamHI/XhoI) using the following oligonucleotides: forward primer: 50-agagagg
gatccatggctgagaagcagaagcac-30 , reverse primer: 50-agagagctcgagcaaacgggctaaagtag
taatc-30 . Myc-AMPKb1 was generated by subcloning human AMPKb1 cDNA
(Addgene plasmid #31,666: pECE-HA-AMPKb1 wt was a gift from Anne
Brunet78) into pCMV-Tag3b (XhoI/ApaI) using the following oligonucleotides:
forward primer: 50-agagagctcgagggcaataccagcagtgagcg-30 , reverse primer: 50-agagag
gggcccgtttaaactatgggcttgtataac-30 . Myc-AMPKg1 was generated by subcloning
human AMPKg1 cDNA (Addgene plasmid #30,308: pFLAG-Cherry-N1-PRKAG1
was a gift from Jay Brenman79) into pCMV-Tag3b (BamHI/XhoI) using the
following oligonucleotides: forward primer: 50-agagagggatccatggagacggtcatttctt
cag-30 , reverse primer: 50-agagagctcgagctagggcttcttctctccacc-30 . Human HA-hULK1
was a gift from Do-Hyung Kim64 and received from Addgene (plasmid #31,963).
Myc-TSC1 was generated by subcloning TSC1 cDNA (Addgene plasmid #19,955:
pcDNA3-myc3-Tsc1 was a gift from Yue Xiong80) into pCMV-Tag3b (SrfI/ApaI)
using the following oligonucleotides: forward primer: 50-agagaggcccgggcatggcc
caacaagcaaatg-30 , reverse primer: 50-gagagggcccttattagctgtgttcatgatgatgag-30 .
Myc-TSC1-C was generated by subcloning TSC1 cDNA into pCMV-Tag3b
(SrfI/ApaI) using the following oligonucleotides: forward primer: 50-agagaggcccggg
ccgcaaggtgatcaaagc-30, reverse primer 50-gagagggcccttattagctgtgttcatgatgatgag-30 .
Myc-TSC1-M was generated by subcloning TSC1 cDNA into pCMV-Tag3b
(SrfI/ApaI) using the following oligonucleotides: forward primer: 50-agagaggcccg
ggccattcggatgactacgtgc-30, reverse primer: 50-agagaggggcccttactctcggtcatgctgcag-30 .
Construct integrities were conﬁrmed by restriction enzyme digests and
automated DNA sequencing (LGC Genomics GmbH).
Site-directed mutagenesis. The generated GFP-WIPI3 encoding construct
(see above) was used as a DNA template and synthesized mutant oligonucleotides
(Sigma-Aldrich) for site-directed mutagenesis (Quick change II; Stratagene) to
generate the following construct encoding mutant WIPI3 protein:
GFP-WIPI3-R230A/R231A (forward primer: 50-ttaatccaggaactggcagcaggatctcaagca
gcc-30 , reverse primer: 50-ggctgcttgagatcctgctgccagttcctggattaa-30).
The GFP-WIPI4 encoding construct32 was used as a DNA template and
synthesized mutant oligonucleotides (Sigma-Aldrich) for site-directed mutagenesis
(Quick change II; Stratagene) to generate the following constructs encoding mutant
WIPI4 proteins.
GFP-WIPI4-N15A (forward primer: 50-accagcctgcgtttcgcccaagaccaaagctgc-30 ,
reverse primer: 50-gcagctttggtcttgggcgaaacgcaggctggt-30), GFP-WIPI4-Q16A
(forward primer: 50-agcctgcgtttcaacgcagaccaaagctgc-30 , reverse primer: 50-gcagctt
tggtctgcgttgaaacgcaggct-30), GFP-WIPI4-D17A (forward primer: 50-tgcgtttcaaccaa
gcccaaagctgcttttgc-30 , reverse primer: 50-gcaaaagcagctttgggcttggttgaaacgca-30),
GFP-WIPI4-E55A (forward primer: 50-gcatgggcttggtggcgatgctgcaccgctc-30 , reverse
primer: 50-gagcggtgcagcatcgccaccaagcccatgc-30), GFP-WIPI4-R109A (forward
primer: 50-ccagtgctttctgtggccatgcgccatgac-30 , reverse primer: 50-gtcatggcgcatggcc
acagaaagcactgg-30), GFP-WIPI4-R111A (forward primer: 50-ctttctgtgcgcatggcccatg
acaagatcg-30 , reverse primer: 50-cgatcttgtcatgggccatgcgcacagaaag-30), GFP-WIPI4-
H112A (forward primer: 50-tctgtgcgcatgcgcgctgacaagatcgtg-30 , reverse primer: 50-ca
cgatcttgtcagcgcgcatgcgcacaga-30), GFP-WIPI4-D113A (forward primer: 50-tgcgcat
gcgccatgccaagatcgtgatcg-30 , reverse primer: 50-cgatcacgatcttggcatggcgcatgcgca-30),
GFP-WIPI4-K114A (forward primer: 50-cgcatgcgccatgacgcgatcgtgatcgtgc-30 ,
reverse primer: 50-gcacgatcacgatcgcgtcatggcgcatgcg-30), GFP-WIPI4-R232A/R233A
(forward primer: 50-aaactggtggagctggccgcaggcactgaccc-30 , reverse primer: 50-gggtc
agtgcctgcggccagctccaccagttt-30), GFP-WIPI4-N15A/D17A (forward primer: 50-acc
agcctgcgtttcgcccaagcccaaagctgc-30 , reverse primer: 50-gcagctttgggcttgggcgaaacgcag
gctggt-30).
Construct integrities were conﬁrmed by restriction enzyme digests and
automated DNA sequencing (LGC Genomics GmbH).
Cell culture. Human U2OS osteosarcoma cell line (ATCC; HTB-96), human G361
malignant melanoma cell line (ATCC; CRL-1424) and m5–7 MEFs (kindly
provided by Noboru Mizushima, Tokyo Medical and Dental University, Japan)
were cultured at 37 C and 5% CO2 in DMEM GlutaMAX (Life Technologies;
31,966) supplemented with 10% fetal calf serum (PAA; A15-043), 100Uml 1
penicillin/100 mgml 1 streptomycin (Life Technologies; 15140-122).
Doxycycline (1mgml 1; Sigma-Aldrich, D9891) was added to m5–7 cells for
the repression of ATG5 cDNA expression in order to obtain ATG5 knockout (KO)
MEF; doxycycline was omitted from the culture medium to obtain ATG5 wild-type
(WT) MEF81.
G418 Sulfate (Life Technologies; 11811-098) was additionally added
(0.6mgml 1) to monoclonal U2OS cell lines stably expressing GFP-WIPI1,
Figure 7 | WIPI4 interacts with ATG2, AMPK and ULK1. (a) U2OS cells transiently expressing GFP-tagged WIPI proteins and myc-ATG2A were starved
and analysed by anti-myc immunoprecipitation and anti-myc and anti-GFP immunoblotting. (b) U2OS cells expressing myc-ATG2A and GFP, GFP-WIPI4
WTor GFP-WIPI4 mutants (N15A, Q16A, D17A, N15A/D17A) were analysed by anti-GFP immunoprecipitation, and anti-myc and anti-GFP immunoblotting.
Amino acids in WIPI4 conferring ATG2 binding are highlighted in red (upper panel). (c) Stable GFP-WIPI1 U2OS cells with shRNAs targeting WIPI4 and
ATG2 (shATG2/shWIPI4) or with shControl were analysed by automated imaging. Aberrant GFP-WIPI1 accumulations are indicated. (d,e) Stable
GFP-WIPI1 or GFP-LC3 U2OS cells were transfected with siATG2 or siControl (fed conditions, F) and images of GFP-WIPI1 cells are shown (d).
(e) GFP-WIPI1 (left, middle panel) and GFP-LC3 puncta (right panel) formation was assessed using up to 13,614 GFP-WIPI1 U2OS cells (n¼ 3) or up to
9,457 GFP-LC3 U2OS cells (n¼ 3) per condition. (f) Stable GFP-WIPI2B, GFP-WIPI4 or GFP U2OS cells expressing myc-ATG2A were fed (F) or starved (S)
and analysed by anti-GFP immunoprecipitation and anti-GFP or anti-AMPKa immunoblotting (n¼ 2). (g) Stable GFP-WIPI4 or GFP U2OS cells expressing
myc-ATG2A were fed (F) or starved (S) for 3 h and analysed by anti-GFP immunoprecipitation and immunoblotting (anti-GFP, anti-myc or anti-Ulk1
antibodies) (n¼ 3 with duplicates). (h) Stable GFP-WIPI4 or GFP U2OS cells expressing myc-ATG2A were analysed by anti-GFP immunoprecipitation
and anti-GFP, anti-myc, anti-Ulk1 or anti-AMPKa immunoblotting. Conditions (3 h): fed (F), starved (S), starved with AICAR (n¼ 3 with duplicates).
(i) The abundance of AMPK co-purifying with GFP-WIPI4 upon AICAR treatment was quantiﬁed (n¼ 3). (j) Stable GFP-WIPI4 cells expressing myc-
ATG2A were treated (3 h) with complete medium (without FCS) lacking glucose (Gluc) or glucose/glutamine (Gluc/Glut), and analysed by anti-GFP
immunoprecipitation and anti-myc, anti-AMPKa and anti-GFP immunoblotting. (k) U2OS cells expressing GFP or GFP-WIPI4 with myc-tagged AMPKa1,
a2, b1 or g1 were analysed by anti-GFP immunoprecipitation and anti-myc and anti-GFP immunoblotting. Additional Supplementary Material is available:
Supplementary Fig. 7. Statistics and source data: Supplementary Data 1. Mean±s.d.; heteroscedastic t-testing; P values: *Po0.05, **Po0.01, ***Po0.001,
ns: not signiﬁcant. Scale bars: 20mm.
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Figure 8 | Glucose-starvation-mediated AMPK activation regulates WIPI4. (a) A lentiviral-based shRNA screening approach targeting the human
kinome used for the assessment of autophagy identiﬁed AMPK and the AMPK-related protein kinases NUAK2 and BRSK2, along with CaMKKa, as
autophagy regulators (for details see Methods section and Supplementary Fig. 8). Reported (red) and predicted (yellow) proteins interactions, and pathway
interactions (blue) are indicated (GeneMANIA). (b) Stable GFP-WIPI1 U2OS cells were transfected with siRNAs for AMPKa, AMPKg, LKB1, CaMKKa,
NUAK2 or BRSK2 and knock-down conﬁrmed by immunoblotting (left panels) or quantitative RT–PCR (right panels). (c) Stable GFP-WIPI4 U2OS cells with
siRNAs targeting AMPKa, AMPKg, LKB1, CaMKKa, NUAK2 or BRSK2 were starved (S) for 3 h. Mean percentages of GFP-WIPI4-puncta-positive cells (300
cells per condition, n¼ 3) are presented. (d) U2OS cells were fed (F) or starved (S) with or without glucose, glutamine or AICAR and immunoblotted using
anti-AMPKa and anti-tubulin antibodies. Stable GFP-WIPI4 U2OS cells (e) or GFP-WIPI1 (f) were fed or treated with complete medium without FCS
( FCS), without glucose ( FCS Gluc) or without glucose and glutamine ( FCS Gluc Glut). Mean percentages of GFP-WIPI4-puncta-positive
cells (300 cells per condition, n¼ 3) (e) and GFP-WIPI1-puncta-positive cells (up to 3,904 cells per condition, n¼ 6) (f) are presented. (g) U2OS cells
expressing GFP-WIPI4 WT or GFP-WIPI4 D113A mutant were fed or glucose-starved ( FCS Gluc) for 3 h. Mean percentages of GFP-WIPI4-puncta-
positive cells (300 cells per condition, n¼ 3) are presented. (h) U2OS cells expressing GFP-WIPI4 WTor GFP-WIPI4 D113A mutant with siControl (siCtr)
or siAMPKa were glucose-starved ( FCS Gluc) for 3 h. Mean percentages of GFP-WIPI4-puncta-positive cells (500 cells per condition, n¼ 5) are
presented. (i) A predicted model for the differential contributions of human WIPI b-propeller proteins in autophagy. Statistics and source data can be found
in Supplementary Data 1. Mean±s.d.; heteroscedastic t-testing; P values: *Po0.05, **Po0.01, ***Po0.001, ns: not signiﬁcant.
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GFP-WIPI2B, GFP-WIPI2D, GFP-LC3 or GFP alone31,36,51 and are here referred
to as stable GFP-WIPI1, GFP-WIPI2B, GFP-WIPI2D, GFP-LC3 or GFP U2OS
cells.
RNA interference. The following lentiviral experiments have been approved
(Az.: Vl-2-7534.45/11, Regierungspra¨sidium Tu¨bingen, Germany) and were
conducted in Biosafety Level 2 laboratory facilities. For generating a stable WIPI2
KD in U2OS and G361 cells and lentiviral packaging, lentiviral WIPI2-targeting
shRNA constructs were obtained (Sigma-Aldrich; TRCN0000154324,
TRCN0000153071); cell infection was conducted at a multiplicity of infection of 20
in the presence of 9 mgml 1 hexadimethrine bromide (Sigma- Aldrich; H9268)
and selection was conducted by using 1 mgml 1 puromycin (Sigma-Aldrich,
P9620) (ref. 82). For the stable KD of either WIPI1, WIPI3, WIPI4 or ATG2A/B
the following lentiviral particles (pLKO.1) were purchased from Sigma-Aldrich and
used to infect U2OS and G361 cells (in the presence of 9 mgml 1 hexadimethrine
bromide; Sigma-Aldrich; H9268) and puromycin (1 mgml 1; Sigma-Aldrich;
P9620) selection: WIPI1 (TRCN0000152), WIPI3 (TRCN0000131124,
TRCN0000147320, TRCN0000128386), WIPI4 (TRCN0000138588,
TRCN0000136607, TRCN0000134205), ATG2A (TRCN0000172342). In addition,
control U2OS and G361 cell lines stably expressing scrambled shRNAs
(Sigma-Aldrich; SHC002) were generated. KD events were veriﬁed by
immunoblotting and quantitative PCR.
Transient KD experiments with siRNAs or esiRNAs were conducted by using
Lipofectamine RNAiMAX (Invitrogen; 13778-075) according to the manufacturer’s
reverse transfection protocol. Brieﬂy, siRNA (25 nM or 50 nM ) or esiRNA (200 ng)
and 0.2 ml Lipofectamine RNAiMAX were diluted in 20 ml OPTI.MEM (Life
Technologies; 51985-026) and the transfection solution incubated for 20min at
room temperature (RT) and added to the well of a 96-well plate. Finally, 10,000
cells (U2OS or G361) in 100 ml DMEM GlutaMAX/10%FCS were added to the
transfection solution for 48 h. KD events were veriﬁed by immunoblotting and
quantitative PCR.
DNA transfection. Transient transfections were conducted by using Promofectine
(Promokine; PK-CT-2000-100) or Lipofectamine 2,000 (Invitrogen; 11668-019)
according to the manufacturer’s instructions. Alternatively, DEAE-Dextran
(Sigma- Aldrich; D9885) was used for large-scale transient transfections and
conducted in 10 cm dishes. Twelve microgram DNA was diluted in 900 ml PBS, and
90ml DEAE-Dextran (10mgml 1) was diluted in 900ml PBS and both solutions
incubated for 5min at RT. Subsequently, the DEAE-Dextran solution was mixed
with the DNA solution and DNA/DEAE-Dextran mixture incubated for 10min at
RT. The cells were washed twice with PBS and the DNA/DEAE-Dextran mixture
was added to the cells. The cells were incubated for 30min at 37 C, 5% CO2 and
every 5min the plates were rocked by hand. Subsequently, 6ml DMEM GlutaMAX
supplemented with 60ml chloroquine (8mM) was added to the cells and incubated
at 37 C, 5% CO2. After 2.5 h, the medium was replaced with 6ml DMEM
GlutaMAX containing 10% DMSO, cells incubated for 90 s, washed with
DMEM GlutaMAX and incubated for 48 h in DMEM GlutaMAX/10% FCS at
37 C, 5% CO2.
Monoclonal U2OS cell lines stably expressing GFP-WIPI3S, GFPWIPI3 or
GFP-WIPI4 have been generated upon transient transfections using Lipofectamine
2,000 (Invitrogen; 11668-019) and G418 selection (0.6mgml 1) (refs 31,36).
Autophagy assay. Cells were incubated in full (fed, F) (DMEMGlutaMAX/10%FCS)
or nutrient-free starvation medium (starved, S) (EBSS; Life Technologies; 24010-043)
in the presence or absence of 200nM baﬁlomycin A1 (AppliChem; A7823), 233nM
wortmannin (Sigma-Aldrich; W1628), 300nM rapamycin (Sigma-Aldrich; R0395),
100mM LY294002 (Sigma-Aldrich; L9908) or 1mM AICAR (Selleckchem; S1802).
Unless stated otherwise, incubation periods were generally conducted for 3 h. For
glucose and glucose/glutamine deprivation the following media were used: DMEM
(Life Technologies; 11965-092), DMEM, no glucose (Life Technologies; 11966-025),
DMEM, no glucose, no glutamine, no phenol red (Life Technologies; A14430-01).
RNA extraction and quantitative PCR. Total RNA was extracted by using the
innuPREP RNA Mini Kit (Analytik Jena AG; 845-KS-2040250) according to
the manufacturer’s instruction. Standard reverse transcription (RT)–PCR was
performed83 with the following TaqMan probes (Applied Biosystems):
Hs00215872_m1 (WIPI1), Hs00255379_m1 (WIPI2), Hs00750495_s1
(WIPI3/WDR45B), Hs01079049_g1 (WIPI4/WDR45), Hs00388292_m1 (NUAK2),
Hs00908871_m1 (BRSK2).
Immunoblotting. Cells were washed with PBS, lysed in hot Laemmli buffer and
boiled for 5min at 95 C. The chromatin was sheared with a 23G needle. Proteins
were separated by SDS–polyacrylamide gel electrophoresis, transferred to a
polyvinylidene diﬂuoride membrane (Millipore; IPVH00010) and subjected to
standard antibody incubation procedures at 4 C and ECL analysis using the
enhanced chemiluminescent substrate from Millipore (WBKLS0500) or Super-
Signal West Femto Maximum Sensitivity Substrate from Thermo Scientiﬁc
(#34,095). ECL was detected by exposure to KODAK BioMAX Films or with the
Fusion SL instrument (Vilber Lourmat). For quantiﬁcation, the Fusion Capt
advance software from Vilber Lourmat was used. For all western blots uncropped
western blot scans along with the locations of molecular weight/size markers and
cropped sections are provided in the Supplementary Information.
Immunopuriﬁcations. Cells were lysed in fresh ACA lysis buffer (750mM
Aminocaproic acid, 50mM Bis-Tris, 0.5mM EDTA, pH 7.0, 0.1% Tween20,
supplemented with Complete EDTA-free protease inhibitor cocktail (Roche;
04693132001), PhosStop phosphatase inhibitor cocktail (Roche; 04906837001).
Cell lysates were mixed (vortex, 10 s), incubated on ice (20min) and the soluble
fractions obtained (centrifugation for 15min at 20,000 g). Immunoprecipitations
were conducted by incubating the soluble fractions with appropriate primary
antibodies for 1 h on ice and subsequent tumbling with 70 ml protein A/G
PLUS-agarose beads (SantaCruz; sc-2003) over night at 4 C. The beads were
washed three times with fresh ACA lysis buffer (see above) and the immunopre-
cipitates subsequently analysed by immunoblotting.
Immunoﬂuorescence. Cells were grown on sterile coverslips and ﬁxed for
10–20min with paraformaldehyde (3.7% in PBS) for direct ﬂuorescence (GFP)
assessments. For indirect immunoﬂuorescence ﬁxed cells were permeabilized
(PBS/0.1% Triton-X) and incubated with Image-iT FX Signal Enhancer (Life
Technologies; I36933). Immunostaining with primary and secondary antibodies
were conducted at 4 C for 60min (ref. 32). and ﬁnally, the cells were mounted on
glass slides using ProLong Gold Antifade Mountant (Life Technologies; P36930).
Low through-put ﬂuorescence microscopy. For general ﬂuorescence microscopy
the Axiovert 200M microscope (Carl Zeiss GmbH) was used. For sub-cellular
localization studies images were acquired by confocal LSM (LSM510; Carl Zeiss
GmbH) with a 63 1.4 DIC Plan-Apochromat oil-immersion objective. Z-stacks
were acquired at an interval of 0.5 mm.
Co-localization events were analysed by assessing ﬂuorescence intensity proﬁles
in individual sections and Z-stacks projections were used for image presentations.
Three-dimensional image models for ﬂy-through movie presentations were
generated from 0.2 mm Z-stack image ﬁles using Volocity 3.1 software
(Improvision)43. The mode isosurface was used to identify a surface around the
objects, where all voxel intensity values were the same.
For autophagy assessments ﬂuorescent punctate structures were counted using
at least 300 cells per condition from three independent experiments. Results were
presented as the percentages of cells displaying punctate structures. The number of
punctate structures per cell was quantiﬁed using confocal images and ImageJ
(Analyse Particles).
Automated high through-put ﬂuorescence microscopy. Automated image
acquisition and analysis was conducted in 96-well cell culture plates. Cells, treated
or not, were ﬁxed in paraformaldehyde (3.7% in PBS), cell nuclei were stained
with 4,6-diamidino-2-phenylindole (DAPI) (AppliChem; 28718-90-3) and if
appropriate immunostaining was conducted. Images were automatically acquired
using the In Cell Analyser 1,000 (GE Healthcare; Nikon Plan Fluor ELWD 40 0,6
objective) and analysed using the In Cell Analyser 1,000 Workstation 3.4 software.
Per well, 25 images were acquired and ﬂuorescence puncta automatically quantiﬁed
using the dual area object assay (IN Cell Analyser Workstation 3.4). Thereby,
DAPI-stained nuclei were detected with a top hat segmentation algorithm
(minimum size of 100 mm2 per nucleus) and GFP overall ﬂuorescence was used to
detect both the cell area and the puncta of each individual cell (multiscale top hat
algorithms): the cell area was detected with a characteristic area of 1,500 mm2 per
cell; puncta (between 0.5 and 5 mm) were detected with an intensity threshold
4200 (puncta intensity over cytoplasmic intensity ﬂuorescene threshold 41.15)
(ref. 36).
Lentiviral-based shRNA screening. MISSION LentiExpress Human Kinases
(Sigma-Aldrich; SHX001) was used to identify human protein kinases that mod-
ulate the number of GFP-WIPI1 punctate structures. Monoclonal U2OS cells stably
expressing GFP-WIPI1 were seeded in 96-well plates pre-containing the lentiviral
particles and 96 h after infection, cells were washed twice with DMEM GlutaMAX.
For elevating basal autophagy cells were incubated in DMEM GlutaMAX (without
FCS) for 3 h, ﬁxed in paraformaldehyde (3.7% in PBS) and stained with DAPI
(AppliChem; 28718-90-3). Automated image acquisition was conducted by using
the In Cell Analyser 1,000 (GE Healthcare; Nikon 40 Planﬂuor objective) and
GFP-WIPI1 punctate structures automatically analysed with the In Cell Analyser
1,000 Workstation 3.4 software31,36. Candidates were chosen for further analysis if
their downregulation resulted in a decrease (o20%) or an increase (445%) of
GFP-WIPI1 puncta-positive cells with at least two different shRNA constructs
targeting the same protein kinase. For a secondary screen corresponding parallel
candidate samples from the MISSION LentiExpress Human Kinases shRNA library
were used to isolate U2OS-GFP-WIPI1 cell lines stably expressing candidate
shRNAs. Therefore, U2OS-GFP-WIPI1 cells were infected with a pool of four
different lentiviruses for each candidate kinase, selected and assessed for
GFP-WIPI1 punctate cells upon starvation in nutrient-free medium (EBSS). Based
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on the P values calculated by comparisons with non-targeting shRNA control cell
lines candidate kinases were chosen for ﬁnal assessments with transient siRNA
transfections. A ﬂow diagram of the screening procedure along with results are
presented in Supplementary Fig. 8.
Electron microscopy. G361 cells were treated with EBSS for 3 h and ﬁxed with
paraformaldehyde (3.7% in PBS) for 30min. The cells were scraped off, collected
and further ﬁxed in 2% glutaraldehyde and 0.5% osmium tetroxide in 0.1 PBS,
dehydrated with ethanol, and embedded in Epon. Thin sections (ultramicrotome
cuts) were contrasted with uranyl acetate and lead citrate and ﬁnally examined in
an EM410 electron microscope (Philipis)84,85. Acquired EM section images
(documented digitally using Ditabis) were used for estimating differences in the
appearance of autophagosomal structures and precursors between control
(shControl) and shWIPI cell lines.
Long-lived protein degradation assay. The proteolysis of long-lived proteins was
assessed by culturing the cells with 0.1 mCi 14C-Valine (Hartmann Analytic;
MC277) for 24 h, washed with PBS, and chased with cold valine (10mM L-Valine;
Sigma-Aldrich; 94,619) for 1 h to remove short-lived proteins52. Upon different
treatments (for example, starvation) cells were lysed with RIPA buffer
supplemented with SDS and proteins precipitated with ice-cold 10% trichloroacetic
acid/1% phosphotungstic acid. Both, the soluble and the insoluble radioactivity was
measured. Proteolysis was calculated as the percentage of TCA-soluble
radioactivity in relation to the insoluble radioactivity.
Phospholipid-protein overlay assay. Native cell extracts (750mM aminocraproic
acid, 50mM Bis-Tris, 0.5mM EDTA, pH 7.0, Protease Inhibitor Cocktail) from
G361 cells or U2OS cells stably expressing GFP-WIPI proteins were obtained and
used to overlay membrane-immobilized phospholipid membranes (Echelon;
P-6001) for standard ECL (WBKLS0500) detection of bound WIPI proteins
(primary antibodies: anti-WIPI1, anti-WIPI2 or anti-WIPI4 (endogenous WIPI
proteins); anti-GFP (GFP-tagged WIPI proteins)38.
MS and analysis. Monoclonal U2OS cell lines stably expressing either of the
GFP-tagged WIPI proteins or GFP alone were subjected to anti-GFP immuno-
precipitations and puriﬁed protein complexes separated in a 12% NUPAGE Novex
Bis-Tris Gel (Invitrogen) in MOPS SDS running buffer (Invitrogen) for 10min at
200V. The NUPAGE gel was stained with Colloidal Blue Staining Kit (Invitrogen),
gel pieces were cut and digested in gel with trypsin as described previously. Peptide
mixtures were desalted using C18 StageTips and separated on the EasyLC nano-
high-performance liquid chromatography HPLC (Proxeon Biosystems) coupled to
an LTQ Orbitrap XL (Thermo Fisher Scientiﬁc). Binding and chromatographic
separation of the peptides was performed on a 15 cm fused silica emitter with an
inner diameter of 75 mm (Proxeon Biosystems), in-house packed with reversed-
phase ReproSil-Pur C18-AQ 3 mm resin (Dr Maisch GmbH). The peptide mixtures
were injected in HPLC solvent A (0.5% acetic acid) at a ﬂow rate of 500 nlmin 1
and subsequently eluted with an 127min segmented gradient of 5-33-50-90% of
HPLC solvent B (80% acetonitrile in 0.5% acetic acid) at a ﬂow rate of
200 nlmin 1. The 10 most intense precursor ions were sequentially fragmented in
each scan cycle using collision-induced dissociation. In all measurements,
sequenced precursor masses were excluded from further selection for 90 s. The
target values were 5,000 charges for MS/MS fragmentation and 106 charges for the
MS scan. Acquired MS spectra were processed with MaxQuant software package
versions 1.2.2.9 with integrated Andromeda search engine. Database search was
performed against a target-decoy H. sapiens database obtained from Uniprot
(downloaded 25 February 2014), containing 88,692 protein entries, and 245
commonly observed contaminants. Trypsin was deﬁned as the protease with a
maximum missed cleavage of two. Oxidation of methionines, N-terminal acet-
ylation, and phosphorylation of serine, threonine and tyrosine were speciﬁed as
variable modiﬁcations, whereas carbamidomethylation on cysteines was deﬁned as
a ﬁxed modiﬁcation. Initial maximum allowed mass tolerance was set to 6 ppm
(for the survey scan) and 0.5Da for collision-induced dissociation fragment ions.
A false discovery rate of 1% was applied at the peptide and protein level57,58,86–89.
The MS proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE90 partner repository with the dataset identiﬁer PXD006119.
Selecting ﬁnal candidates for this study here (see Supplementary Data 2), the
following criteria were applied: (1) nuclear proteins (Uniprot gene ontology)
identiﬁed were excluded, (2) proteins identiﬁed in GFP control complexes were
excluded unless the peptide count of proteins identiﬁed in GFP-WIPI
immunocomplexes divided by the peptide counts of proteins of the GFP control
samples was higher than 10, (3) the sum of all peptide counts in independent sets
was higher than 2, (4) peptides were identiﬁed in at least two independent
experiments. For the identiﬁcation of WIPI3-interacting proteins only the proteins
with peptide counts present in the GFP control samples were excluded.
GeneMANIA was used to visualize interactions identiﬁed in our study and to
distinguish from previously reported or predicted interactions (network category
‘physical interactions’, weighting over 10).
Subcellular fractionation. A crude lysosomal fraction (CLF) was prepared from
2 108 U2OS-GFP-WIPI3 cells cultured for 3 h in DMEM GlutaMAX/10% FCS
supplemented with 200 nM Baﬁlomycin A1. The cells were homogenized with a
Dounce homogenizer (Pestle B), and two subsequent centrifugation steps at 1,000 g
for 10min and for 20min at 20,000 g. Further puriﬁcation of CLF was conducted
by using the Lysosomal Isolation Kit (LYSISO1; Sigma-Aldrich). Brieﬂy, extraction
buffer was added to the pellet containing the CLF. To enrich lysosomes option A
and B were used according to the manufacturer’s protocol. Fractions of 500 ml were
collected from the top of the gradient and used for immunoblot analysis.
Structural homology modelling and sequence alignment. Structural homology
models for WIPI1, WIPI2B, WIPI3 and WIPI4 were generated using the HHpred
web-service32,41 and selecting the PDB structure 3vu4 (Kluyveromyces marxianus)
as model reference. The multiple WIPI protein sequence alignment was generated
by combining the pairwise alignments generated by HHpred to the reference
structure 3vu4. Inconsistent gapping between the pairwise alignments and 3vu4 at
the end of structural elements or within loops were manually resolved using the
program AlnEdit (Java-based alignment editor at Konstanz University Applied
Bioinformatics Lab http://bioinformatics.uni-konstanz.de/programs/alnedit/).
Statistical analysis. Statistical analysis of the data was performed by two-tailed
heteroscedastic t-testing. P values o0.05 were taken to be statistically signiﬁcant
(*Po0.05; **Po0.01, ***Po0.001).
Data availability. Source data for Figures and Supplementary Figs are provided as
Supplementary Data Files with the article. Other data that support the ﬁndings of
this study are available via GenBank (https://www.ncbi.nlm.nih.gov/genbank/) with
identiﬁer KX434429, and via ProteomeXchange (http://www.proteomexchange.-
org/) with identiﬁer PXD006119. All other relevant data supporting the ﬁndings of
this study are available on request.
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